Fig. 3From: Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes—a single centre analysisPFS estimates for initial RT/re-RT for patients with locoregional recurrence of head and neck squamous cell carcinoma (LR-HNSCC). Valid n = 101, analysis according to Kaplan–Meier. PFS = progression-free survivalBack to article page
